RE:But nobody knows anything?If the market figure it out in less than 16 days since Jan 13th, that the placebo effect is linked to incorrect used of statins (in 5 sites) at randomization rather that 8 weeks before.
We can only presume that management if aware and some big players are buying before the PR.
As this point, the only thing we care is placebo at 10% or less. T2 results won't have the same problem.
Secondary end points will be release by February end and this situation will be part of history.
Peace and enjoy.
GLTA